Outlook Therapeutics (OTLK) Revenue (2015 - 2025)
Outlook Therapeutics (OTLK) reported Revenue of -$91787.0 for Q3 2025, down 106.1% quarter-over-quarter from $1.5 million in Q2 2025.
Outlook Therapeutics (OTLK) Revenue (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has 6 years of Revenue data on file, last reported at -$91787.0 in Q3 2025.
- Revenue for Q3 2025 came in at -$91787.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $7.9 million (changed N/A YoY), and the FY2025 annual result was $1.4 million, changed N/A from the prior year.
- Revenue eased to -$91787.0 in Q3 2025 per OTLK's latest filing, from $1.5 million in the prior quarter.
- Over five years, Revenue peaked at $1.5 million in Q2 2025 and troughed at -$91787.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -91,787.00 |
| Jun 30, 2025 | 1.51 Mn |
| Sep 30, 2019 | 5.85 Mn |
| Jun 30, 2019 | 583,848.00 |
| Mar 31, 2019 | 641,140.00 |
| Dec 31, 2018 | 1.07 Mn |
| Sep 30, 2018 | 771,890.00 |
| Jun 30, 2018 | 771,890.00 |
| Mar 31, 2018 | 771,890.00 |
| Dec 31, 2017 | 771,890.00 |
| Sep 30, 2017 | 2.90 Mn |
| Jun 30, 2017 | 303,140.00 |
| Mar 31, 2017 | 303,140.00 |
| Dec 31, 2016 | 303,140.00 |
| Sep 30, 2016 | 494,894.00 |
| Jun 30, 2016 | 494,894.00 |
| Mar 31, 2016 | 994,894.00 |
| Dec 31, 2015 | 994,894.00 |
| Sep 30, 2015 | 494,894.00 |
| Jun 30, 2015 | 1.29 Mn |